CA
NZ
UK
AU
IND
US
Actinium Pharmaceuticals, Inc. (NYSE American:ATNM) announced on November 4, 2026 that an abstract evaluating long-term safety and tolerability of Actimab-A (lintuzumab-Ac225) in combination with CLAG-M intensive salvage chemotherapy in relapsed or refractory acute myeloid leukemia patients will be presented at the 2026 American Society …
Charles River Laboratories International, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 4, 2026, covering the fiscal quarter ended September 26, 2026.
Luxfer Holdings PLC filed a Form 8-K on November 4, 2026, disclosing that shareholders approved the proposed acquisition by Double Eagle Acquisition Buyer, Inc., a holding company owned by funds managed by Wynnchurch Capital, L.P., at a cash consideration of $17.37 per ordinary share.
AeroVironment, Inc. filed a Form 8-K on November 4, 2026, disclosing that it entered into a Sixth Amendment to its Credit Agreement on October 30, 2026, increasing its aggregate revolving commitments by $100 million and adding BMO Bank N.A. as a new lender.
Penguin Solutions, Inc. filed an 8-K on November 4, 2026, disclosing that it entered into an Equity Purchase Agreement on November 3, 2026, to sell its Cree LED business, which comprises its Optimized LED segment, to Transom Crystal AcquireCo, LLC, an affiliate of Transom …
Lyell Immunopharma, Inc. filed a Form 8-K with the SEC on November 4, 2026, disclosing a Securities Purchase Agreement dated November 3, 2026, to sell 7,428,040 shares of common stock in a private placement expected to generate approximately $80.0 million in gross proceeds.
ADC Therapeutics SA filed an 8-K on November 4, 2026, announcing that new and updated clinical data from the ZYNLONTA (loncastuximab tesirine-lpyl) program will be presented across five oral sessions and multiple posters at the 68th American Society of Hematology Annual Meeting, December 12-15, …
Flowers Foods, Inc. announced on November 4, 2026 that its board of directors elected Shaun P. Mara and Ken Plunk as independent directors, effective November 18, 2026, expanding the board to 10 members.
Morgan Stanley Finance LLC filed a Free Writing Prospectus to Preliminary Pricing Supplement No. 19,851 on November 4, 2026, for Market Linked Securities linked to the common stock of SoFi Technologies, Inc., due November 9, 2028, and fully and unconditionally guaranteed by Morgan Stanley.
Shionogi & Co. Ltd filed a Schedule 13G with the SEC on November 4, 2026, reporting beneficial ownership of 2,953,817 shares of Apnimed, Inc. common stock as of September 30, 2026.
Please wait processing your request...